TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis.
Melotti S, Ambrosi F, Franceschini T, Giunchi F, Filippo GD, Franchini E, Massari F, Mollica V, Tateo V, Bianchi FM, Colecchia M, Acosta AM, Lobo J, Fiorentino M, Ricci C.
Pathol Res Pract. 2023 Jul;247:154540. doi: 10.1016/j.prp.2023.154540. Epub 2023 May 18.
PMID:37209574
Mixed germ cell-sex cord stromal tumour of the testis and ovary: comparison and contrast.
Roth LM, Cheng L.
Pathology. 2021 Feb;53(2):166-169. doi: 10.1016/j.pathol.2020.10.008. Epub 2020 Dec 25.
PMID:33358757
Novel insights into the mixed germ cell-sex cord stromal tumor of the testis: detection of chromosomal aneuploidy and further morphological evidence supporting the neoplastic nature of the germ cell component.
Michalova K, McKenney JK, Kristiansen G, Steiner P, Grossmann P, Putzova M, Martinek P, Chottova-Dvorakova M, Michal M, Hes O, Michal M.
Virchows Arch. 2020 Nov;477(5):615-623. doi: 10.1007/s00428-020-02843-3. Epub 2020 May 23.
PMID:32447491
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M, Paffenholz P, Ruf C, Che Y, Seidel C, Heinzelbecker J, Schmelz HU, Matthies C, Albers P, Bokemeyer C, Heidenreich A, Pichler M, Nestler T; GTCSG (German Testicular Cancer Study Group).
Cancer Med. 2023 Aug;12(16):16829-16836. doi: 10.1002/cam4.6304. Epub 2023 Jul 1.
PMID:37392170
Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.